Myopia and hyperopia are associated with opposite chronotypes in a sample of 71,016 individuals - Palumaa, Teele; Taba, Nele; Teder-Laving, Maris; Kivi, Kadi-Liis; Reis, Kadri; Võsa, Urmo; Estonian Biobank Research Team; Esko, Tõnu; Abner, Erik (medRxiv, 2024)
Myopia, projected to affect half of the global population by 2050, is a growing healthcare concern. Chronotype, an output of the human biological clock, and sleep parameters have been associated with several diseases, including myopia. We explored the connection between refractive errors and sleep and circadian rhythm parameters by employing a sample of 71,016 adults who completed the Munich Chronotype Questionnaire in the Estonian Biobank. After accounting for possible confounders, such as age, sex, education level, and duration of daylight exposure, we observed that individuals with late chronotype, characterised by a delayed sleep-wake pattern on free days, had higher odds for myopia. In contrast, early chronotype was associated with hyperopia. Furthermore, increased social jet lag and reduced sleep duration were associated with both myopia and hyperopia. These results emphasise the complex interplay between circadian rhythms and sleep in refractive development, with potential implications for public health and clinical practice.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the European Union through Horizon 2020 research and innovation programme under grants no 810645 and 894987, through the European Regional Development Fund project no. MOBEC008, and the Estonian Research Council grants PRG1291 and PRG1414.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Estonian Committee on Bioethics and Human Research (Estonian Ministry of Social Affairs) gave ethical approval for this work (approval 1.1-12/624).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesPseudonymised genotype and phenotype data are available from the Estonian Biobank (https://genomics.ut.ee/en/content/estonian-biobank) upon request.